Moderna's employees to receive its COVID-19 vaccine

 

• Rising 2.3% in premarket trading, Moderna (NASDAQ:MRNA) shares are continuing yesterday’s gains as the COVID-19 vaccine maker announces a vaccination program for its employees and a new vaccine order from South Korea.
• In an arrangement separate from the millions of doses agreed for the U.S. government, its employees, contractors, and board members will receive the newly approved COVID-19 vaccine, the Wall Street Journal reports.
• The company's vaccination drive extends to adult members of its workers’ households to reduce the work disruption caused by possible infection to family members of employees.
• The approach looks different from the stance taken by Pfizer (NYSE:PFE) for its COVID-19 vaccine co-developed with the German partner, BioNTech (NASDAQ:BNTX). For eligibility requirements in vaccinating the employees, the company, which had about 88,300 at last year-end, plans to follow the CDC guidelines.
• Meanwhile, Moderna has announced it is in discussion with the government of South Korea to supply 40M or more doses of its COVID-19 vaccine beginning 2Q 2021.
• Moderna has agreed to supply 20M doses for the U.S. by the month-end, but according to CDC data, only about 11.4M doses from both approved vaccine makers had been dispatched since December 13.
• https://seekingalpha.com/news/3647864-modernas-employees-to-receive-covidminus-19-vaccine